The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
In Vivo Tumor Targeting and Image-Guided Drug Delivery with Antibody-Conjugated, Radiolabeled Mesoporous Silica Nanoparticles
Open accessAbstract
Since the first use of biocompatible mesoporous silica (mSiO2) nanoparticles as drug delivery vehicles, in vivo tumor targeted imaging and enhanced anticancer drug delivery has remained a major challenge. In this work, we describe the development of functionalized mSiO2 nanoparticles for actively targeted positron emission tomography (PET) imaging and drug delivery in 4T1 murine breast tumor-bearing mice. Our structural design involves the synthesis, surface functionalization with thiol groups, PEGylation, TRC105 antibody (specific for CD105/endoglin) conjugation, and (64)Cu-labeling of uniform 80 nm sized mSiO2 nanoparticles. Systematic in vivo tumor targeting studies clearly demonstrated that (64)Cu-NOTA-mSiO2-PEG-TRC105 could accumulate prominently at the 4T1 tumor site via both the enhanced permeability and retention effect and TRC105-mediated binding to tumor vasculature CD105. As a proof-of-concept, we also demonstrated successful enhanced tumor targeted delivery of doxorubicin (DOX) in 4T1 tumor-bearing mice after intravenous injection of DOX-loaded NOTA-mSiO2-PEG-TRC105, which holds great potential for future image-guided drug delivery and targeted cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Cited by
Mesoporous Silica Nanoparticles for Drug Delivery
Manzano, M., & Vallet‐Regí, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201902634 · Cited by 939
Magnetically Driven Micro and Nanorobots
Zhou, H., Mayorga-Martinez, C. C., Pané, S., Zhang, L., & Pumera, M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01234 · Cited by 889
Clearance Pathways and Tumor Targeting of Imaging Nanoparticles
Yu, M., & Zheng, J. (2015) · ACS Nano · doi:10.1021/acsnano.5b01320 · Cited by 886
Mesoporous silica nanoparticles for drug and gene delivery
Zhou, Y., Quan, G., Wu, Q., Zhang, X., Niu, B., Wu, B., Huang, Y., Pan, X., & Wu, C. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.01.007 · Cited by 706
Croissant, J. G., Fatieiev, Y., Almalik, A., & Khashab, N. M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700831 · Cited by 594
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
Vallet-Regí, M., Colilla, M., Izquierdo-Barba, I., & Manzano, M. (2017) · Molecules · doi:10.3390/molecules23010047 · Cited by 538
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 507
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Nanoscale metal−organic frameworks for combined photodynamic & radiation therapy in cancer treatment
Liu, J., Yang, Y., Zhu, W., Yi, X., Dong, Z., Xu, X., Chen, M., Yang, K., Lu, G., Jiang, L., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.034 · Cited by 447
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers
Zhao, Z., Ukidve, A., Krishnan, V., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.002 · Cited by 444
Multifunctional surface microrollers for targeted cargo delivery in physiological blood flow
Alapan, Y., Bozuyuk, U., Erkoc, P., Karacakol, A. C., & Sitti, M. (2020) · Science Robotics · doi:10.1126/scirobotics.aba5726 · Cited by 414
Stem Cell Membrane‐Coated Nanogels for Highly Efficient In Vivo Tumor Targeted Drug Delivery
Gao, C., Lin, Z., Jurado‐Sánchez, B., Lin, X., Wu, Z., & He, Q. (2016) · Small · doi:10.1002/smll.201600624 · Cited by 359
Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy
Kamkaew, A., Chen, F., Zhan, Y., Majewski, R. L., & Cai, W. (2016) · ACS Nano · doi:10.1021/acsnano.6b01401 · Cited by 355
Self-citationLigand-installed nanocarriers toward precision therapy
Mi, P., Cabral, H., & Kataoka, K. (2020) · Advanced Materials · doi:10.1002/adma.201902604 · Cited by 350
Yang, G., Gong, H., Liu, T., Sun, X., Cheng, L., & Liu, Z. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.053 · Cited by 292
Nanobody: The “Magic Bullet” for Molecular Imaging?
Chakravarty, R., Goel, S., & Cai, W. (2014) · Theranostics · doi:10.7150/thno.8006 · Cited by 288
Self-citationBiodegradable and Renal Clearable Inorganic Nanoparticles
Ehlerding, E. B., Chen, F., & Cai, W. (2016) · Advanced Science · doi:10.1002/advs.201500223 · Cited by 277
Self-citationAdvances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
Baeza, A., Colilla, M., & Vallet-Regí, M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.953051 · Cited by 270
A targeted approach to cancer imaging and therapy
Li, C. (2014) · Nature Materials · doi:10.1038/nmat3877 · Cited by 268
Ali, E. S., Sharker, S. M., Islam, M. T., Khan, I. N., Shaw, S., Rahman, M. A., Uddin, S. J., Shill, M. C., Rehman, S., Das, N., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.011 · Cited by 267
Zheng, Z., Chen, Y., Guo, B., Wang, Y., Liu, W., Sun, J., & Wang, X. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.125241 · Cited by 108
Tang, Z., Zhang, L., Wang, Y., Li, D., Zhong, Z., & Zhou, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.06.038 · Cited by 73
Molecular Imaging and Nanotechnology—Emerging Tools in Diagnostics and Therapy
Woźniak, M., Płoska, A., Siekierzycka, A., Dobrucki, L. W., Kalinowski, L., & Dobrucki, I. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052658 · Cited by 59
Liu, W., Zhu, Y., Wang, F., Li, X., Liu, X., Pang, J., & Pan, W. (2018) · Royal Society Open Science · doi:10.1098/rsos.181027 · Cited by 59
Metadata
- Authors
- Chen, F., Hong, H., Zhang, Y., Valdovinos, H. F., Shi, S., Kwon, G. S., Theuer, C. P., Barnhart, T. E., & Cai, W.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-10-01
- Volume
- 7
- Issue
- 10
- Pages
- 9027-9039
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W1973008689
- Cited by
- 346
- References
- 3
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.